Navigation Links
Carreras Foundation to Endow Clinical-Research Chair at Fred Hutchinson Cancer Research Center
Date:10/16/2007

Internationally renowned tenor expresses gratitude for successful treatment

SEATTLE, Oct. 16 /PRNewswire/ -- The Friends of Jose Carreras International Leukemia Foundation has announced it will endow a chair for clinical research at Fred Hutchinson Cancer Research Center in honor of E. Donnall Thomas, M.D., who pioneered the bone-marrow transplant.

The Foundation cites a strong wish to honor Carreras and Thomas, emeritus director of clinical research at the Hutchinson Center. Thomas' research in bone-marrow transplantation has saved thousands of lives and won the 1990 Nobel Prize in physiology or medicine.

In 1987, Carreras was diagnosed with acute lymphoblastic leukemia and traveled to the Hutchinson Center for what proved to be a successful series of treatments, including a bone-marrow transplant. In 1988, in deep gratitude to both science and society for the life-saving treatment and the care and affection he received during his illness, Carreras enlisted the help of noted physicians and scientists to initiate the Fundacion Internacional Josep Carreras in his hometown of Barcelona.

"I want to express my deepest admiration for the work of the Fred Hutchinson Cancer Research Center and its dedication toward science, leukemia patients and their families," Carreras said. "The Hutchinson Center and the Foundation share a common goal: to achieve that leukemia becomes one day a totally curable disease, always and for everyone. It is a real pleasure to collaborate with the Fred Hutchinson Cancer Research Center, and especially with an admirable person like Dr. Thomas."

"There are innumerable links that bind me with the Fred Hutchinson Cancer Research Center and with Dr. Thomas. It is an honor and a great responsibility to continuously count on the trust, help and support of the Hutchinson Center and Dr. Thomas," Carreras said.

The Spanish Carreras foundation and branch foundations in the United States, Germany and Switzerland concentrate their efforts in four main areas: funding scientific research, health care infrastructure, promotion of transplantation, and social service to leukemia patients and their families. In addition to funding leukemia research, the Spanish Carreras foundation has worked to establish a bone-marrow registry in Spain. The foundation and its affiliates have helped support dozens of scientists worldwide, including annual fellowships for promising early-career scientists at the Center and throughout the world.

The Jose Carreras/E. Donnall Thomas Endowed Chair for Cancer Research will be awarded to a full member of the Center's Clinical Research Division who spends at least 75 percent of his/her time in research. Candidates will be nominated by their peers and selected by a committee chaired by the Center's president and director. They must have an international reputation for excellence in their field of research and, in addition, will have independent grant support.

In September, Thomas and Center colleagues celebrated the 50th anniversary of his groundbreaking paper on the promise of human bone-marrow transplantation in the New England Journal of Medicine.

At Fred Hutchinson Cancer Research Center, our interdisciplinary teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our researchers, including three Nobel laureates, bring a relentless pursuit and passion for health, knowledge and hope to their work and to the world. For more information, please visit http://www.fhcrc.org.

CONTACT

Christi Ball Loso

(206) 667-5215

closo@fhcrc.org


'/>"/>
SOURCE Fred Hutchinson Cancer Research Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Woodruff Foundation Grant To Support Doctorate Of Nursing Practice Program
2. Kalam To Lay Foundation Of Vellore Research Center
3. Nippon Foundation To Help Leprosy Patients
4. Parents Launch SV40 Cancer Foundation In Memory of Son
5. Cancer Aid And Research Foundation: Offering Endless Hope To Cancer Patients
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. PM Launches Healthcare Foundation For India
8. Prime Minister Manmohan Singh, Flags Off Public Health Foundation of India
9. Gates Foundation to donate USD 104 million to TB Alliance
10. MoU for HIV/AIDS Signed by Nigeria and Clinton Foundation
11. Gates Foundation Adopts Fight against Encephalitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... 2017 , ... The Center for Autism and Related Disorders ... Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The events ... films in an environment that accommodates their unique needs. , Launched in January, ...
(Date:2/23/2017)... ... 2017 , ... Curemark, LLC announced today that the Blüm Study, a Phase ... 3-8 with Autism, is now enrolling at three new sites. These new sites are ... , “There are currently no approved drugs that address the core symptoms of ...
(Date:2/22/2017)... ... February 22, 2017 , ... When it came ... contact center in Georgia, PENETRON Specialty Products (PSP) provided the solution. January’s grand ... recently invested $51 million to purchase and renovate the 185,000 square-foot office complex, ...
(Date:2/22/2017)... , ... February 22, 2017 , ... The Waismann ... the thousands of individuals who have recently fallen victim to America’s opioid epidemic. Now, ... Orange County, California, where they are free from the shame, stigma, and harmful ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... to fewer trips the emergency room, fewer hospital admissions, and better blood pressure ... Managed Care® (AJMC®) finds. The study can be found here . , ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Prosthetic Devices Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 9.2% over the next ... industry report analyzes the market estimates and forecasts for all the ...
(Date:2/23/2017)... 23, 2017 MabVax Therapeutics Holdings, ... development company, announces that it has received notice ... authorizing the initiation a Phase I clinical trial ... cancer. MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s ... to initiate the phase I clinical trial in ...
(Date:2/23/2017)... , Feb. 22, 2017 Orthopedic ... implant demand, as aging demographic patterns lead to ... Implants for sports- and exercise-related injuries, chronic back ... will lead sales gains. The future of medical ... addresses the following questions and more: - ...
Breaking Medicine Technology: